Gerlach Ruediger, Krause Manuela, Seifert Volker, Goerlinger Klaus
Department of Neurosurgery, Johann Wolfgang Goethe University, Schleusenweg 2-16, 60528 Frankfurt am Main, Germany.
Acta Neurochir (Wien). 2009 Aug;151(8):873-900; discussion 900. doi: 10.1007/s00701-009-0409-z. Epub 2009 Jun 26.
Abnormalities of the hemostasis can lead to hemorrhage, and on the other hand to thrombosis. Intracranial neoplasms, complex surgical procedures, and head injury have a specific impact on coagulation and fibrinolysis. Moreover, the number of neurosurgical patients on medication (which interferes with platelet function and/or the coagulation systems) has increased over the past years.
The objective of this review is to recall common hemostatic disorders in neurosurgical patients on the basis of the "new concept of hemostasis". Therefore the pertinent literature was searched to provide a structured and up to date manuscript about hemostasis in Neurosurgery.
According to recent scientific publications abnormalities of the coagulation system are discussed. Pathophysiological background and the rational for specific (cost)-effective perioperative hemostatic therapy is provided.
Perturbations of hemostasis can be multifactorial and maybe encountered in the daily practice of neurosurgery. Early diagnosis and specific treatment is the prerequisite for successful treatment and good patients outcome.
止血功能异常可导致出血,另一方面也可导致血栓形成。颅内肿瘤、复杂的外科手术和头部损伤对凝血和纤溶有特定影响。此外,在过去几年中,服用干扰血小板功能和/或凝血系统药物的神经外科患者数量有所增加。
本综述的目的是基于“止血新概念”回顾神经外科患者常见的止血障碍。因此,检索了相关文献,以提供一篇关于神经外科止血的结构化且最新的手稿。
根据最近的科学出版物,讨论了凝血系统异常。提供了病理生理背景以及特定(成本)效益高的围手术期止血治疗的理论依据。
止血功能紊乱可能是多因素的,在神经外科的日常实践中可能会遇到。早期诊断和特异性治疗是成功治疗和患者良好预后的前提。